Rare Disease - experienced Safety Surveillance Advisers
Denne stilling er desværre ikke længere ledig.
Se alle ledige stillinger
Søborg
Do you want to lead and drive safety surveillance activities in development projects in rare diseases? And would you like to be part of one of the most skilled and advanced pharmacovigilance functions in Denmark? We are expanding and therefore have open positions for experienced candidates in the Safety Surveillance Rare Disease team at . Apply today for a life-changing career! About the Teams
Safety Surveillance Rare Disease is a team within Global Safety at . Our dedicated and skilled professionals have global responsibility for the establishment of the product safety profile during clinical development, and for performing critical analysis and medical evaluation of the emerging aggregate safety data. Due to an increase in the number of development projects, our team is expanding. In the Rare Disease team, we handle projects within the rare disease indication from development to post marketing. You will in collaboration with other colleagues in the team, be responsible for surveillance activities related to the compounds in development for rare blood and bleeding disease indications. The Position
Responsibilities may include: Chair cross-functional drug safety committees. Prepare communication about the benefit risk assessment. Contribute to development of clinical study designs and protocols. Communicate with external parties related to clinical safety monitoring such as Data Monitoring Committees. Represent Safety Surveillance in cross-functional teams. You will get the opportunity both to work independently and in collaboration with a team of highly skilled, committed, and enthusiastic colleagues across the functional areas in Novo Nordisk, especially the Non-clinical and Clinical Development teams. Assuming responsibility, communicating information and taking action will be essential parts of your workday. Qualifications
As an ideal candidate, you will have: A Master’s degree within Medicine or Natural Sciences (MD, DVM, MSc Pharm or equivalent), possibly complemented by a PhD/research experience Preferably several years of experience within pharmacovigilance, or within the pharmaceutical industry and a strong desire to specialise within safety surveillance Interest/experience in data analysis and analysis tools (e.g.Jmp and/or Qliksense) A solid understanding of medical concepts, scientific methodology, and drug development Curiosity to explore new ways of analysing data (e.g. could be in the form of optimizing current ways of working) The ability to work independently as well as to collaborate in a continuous developing environment
It is important that you are a strong collaborator who thrives in a multicultural environment of continuous development, and that you are good at establishing contacts and collaborating with stakeholders out in the organisation as well as external stakeholder’s. As a person, you are self-driven and able to work independently and under pressure when needed. You are ethical, responsible, well-organised and a strong communicator. Working at
At , we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care. Contact
For further information, please contact Safety Surveillance Rare Disease Manager: Michala Gauguin at + Deadline
21 May 2024. Please include a few sentences about why you are applying for the position in your resume or CV. You do not need to attach a cover letter to your application. To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV. We are looking for several Safety profiles at . Therefore, hiring Managers from different teams might also look at your application. Please indicate in your application if we are not allowed to share your application. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Safety Surveillance Rare Disease is a team within Global Safety at . Our dedicated and skilled professionals have global responsibility for the establishment of the product safety profile during clinical development, and for performing critical analysis and medical evaluation of the emerging aggregate safety data. Due to an increase in the number of development projects, our team is expanding. In the Rare Disease team, we handle projects within the rare disease indication from development to post marketing. You will in collaboration with other colleagues in the team, be responsible for surveillance activities related to the compounds in development for rare blood and bleeding disease indications. The Position
Responsibilities may include:
As an ideal candidate, you will have:
It is important that you are a strong collaborator who thrives in a multicultural environment of continuous development, and that you are good at establishing contacts and collaborating with stakeholders out in the organisation as well as external stakeholder’s. As a person, you are self-driven and able to work independently and under pressure when needed. You are ethical, responsible, well-organised and a strong communicator. Working at
At , we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing and sales – we’re all working to move the needle on patient care. Contact
For further information, please contact Safety Surveillance Rare Disease Manager: Michala Gauguin at + Deadline
21 May 2024. Please include a few sentences about why you are applying for the position in your resume or CV. You do not need to attach a cover letter to your application. To ensure an efficient and fair recruitment process, please refrain from adding a photo to your CV. We are looking for several Safety profiles at . Therefore, hiring Managers from different teams might also look at your application. Please indicate in your application if we are not allowed to share your application. We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. At we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Information og data
Denne ledige stilling har jobtypen "Apoteker", og befinder sig i kategorien "Sundhed og forskning".
Arbejdsstedet er beliggende i Søborg.
Jobbet er oprettet på vores service den 4.4.2024, men kan have været deaktiveret og genaktiveret igen.
Dagligt opdateret: Dette job opdateres dagligt ud fra jobudbyderens hjemmeside via vores søgemaskineteknologi og er aktivt lige nu.
- Apoteker
- Søborg
Lignende jobs
-
Apoteker i Søborg
We are expanding our product and project pipeline in Novo Nordisk and are looking for an engaged RA CMC Expert with expertise in small molecules to join RA CMC Emerging Technologies (ET) in [xxxxx]Få mere info- Apoteker
- Søborg
-
Apoteker i Søborg
Do you want to be part of transforming the way Regulatory Affairs operates ensuring compliant and efficient processes in a global pharma company? This role is an excellent opportunity to make a sig..Få mere info- Apoteker
- Søborg
-
Apoteker i Søborg
Exciting Senior Career Opportunity in Regulatory Affairs Combination Products! Do you dream of a career with a global pharmaceutical company built on life-changing innovative investigational med..Få mere info- Apoteker
- Søborg
-
Apoteker i Søborg
Are you ready to explore the thrilling realm of Regulatory Affairs at [xxxxx]? Do you have a robust scientific background and a passion for advancing treatments in cardiometabolic and renal .Få mere info- Apoteker
- Søborg
Statistik over udbudte jobs som apotekere i Søborg
Herunder ser du udviklingen i udbudte apoteker i Søborg over tid. Bemærk at jobs der ikke har en bestemt geografi ikke er medtaget i tabellen. I den første kolonne ser du datoen. I den næste kolonne ser du det samlede antal apotekere.
Se flere statistikker her:
Statistik over udbudte apotekere over tid
| Dato | Alle jobs som apotekere |
|---|---|
| 10. juni 2024 | 5 |
| 9. juni 2024 | 10 |
| 8. juni 2024 | 9 |
| 7. juni 2024 | 9 |
| 6. juni 2024 | 8 |
| 5. juni 2024 | 8 |
| 4. juni 2024 | 11 |
| 3. juni 2024 | 11 |
| 2. juni 2024 | 11 |
| 1. juni 2024 | 13 |
| 31. maj 2024 | 13 |
| 30. maj 2024 | 13 |
| 29. maj 2024 | 13 |
| 28. maj 2024 | 13 |
| 27. maj 2024 | 10 |
| 26. maj 2024 | 10 |
| 25. maj 2024 | 10 |
| 24. maj 2024 | 10 |
| 23. maj 2024 | 10 |
| 22. maj 2024 | 8 |
| 21. maj 2024 | 16 |
| 20. maj 2024 | 16 |
| 19. maj 2024 | 16 |
| 18. maj 2024 | 16 |
| 17. maj 2024 | 12 |
| 16. maj 2024 | 12 |
| 15. maj 2024 | 11 |
| 14. maj 2024 | 11 |
| 13. maj 2024 | 11 |
| 12. maj 2024 | 13 |
| 11. maj 2024 | 13 |